Literature DB >> 21642929

Taking hypoglycaemia seriously: diabetes, dementia and heart disease.

Paula Holt1.   

Abstract

Hypoglycaemia is a common and potentially deadly problem for people with diabetes who are prescribed insulin secretagogues and/or insulin as part of their treatment regimen. This article focuses mainly on type 2 diabetes and considers the incidence, pharmacological causes and definition of hypoglycaemia. It discusses the recently defined relationships between hypoglycaemia and the onset and development of dementia and cardiovascular disease. Hypoglycaemia risk factors are identified and linked to specific characteristics found in the elderly, and information is offered on how to treat hypoglycaemia effectively and avoid repeated episodes.

Entities:  

Mesh:

Year:  2011        PMID: 21642929     DOI: 10.12968/bjcn.2011.16.5.246

Source DB:  PubMed          Journal:  Br J Community Nurs        ISSN: 1462-4753


  4 in total

1.  Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.

Authors:  Elke R Fährmann; Laura Adkins; Cameron J Loader; Hyoil Han; Kevin M Rice; James Denvir; Henry K Driscoll
Journal:  Diabetes Res Clin Pract       Date:  2014-10-23       Impact factor: 5.602

Review 2.  Hypoglycemia, diabetes, and cardiovascular disease.

Authors:  Janet K Snell-Bergeon; R Paul Wadwa
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

3.  Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.

Authors:  Kristine Yaffe; Cherie M Falvey; Nathan Hamilton; Tamara B Harris; Eleanor M Simonsick; Elsa S Strotmeyer; Ronald I Shorr; Andrea Metti; Ann V Schwartz
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

4.  Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu.

Authors:  Shiva Mansouri; Grazyna Lietzau; Mathias Lundberg; David Nathanson; Thomas Nyström; Cesare Patrone
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.